Conference Coverage

FDA’s Woodcock: Give biosimilars a chance

BOSTON – Biosimilar drugs are not identical twins of original biologic agents, but there are very strong family ties, and the newcomer is expected...

News from the FDA/CDC

FDA approves biosimilar adalimumab

There are “no clinically meaningful differences” between Amgen’s biosimilar adalimumab (Amjevita) and AbbVie’s branded product Humira, the Food...